Healthcare
PreveCeutical Medical Inc.(PRVCF)
Live Price
Offline$0.0104
+0.00% today
Window Change
+9.47%
Window
May 29, 2026 โ Jun 15, 2026
- Market Cap
- $10.00M
- Revenue Growth
- 0.0%
- EPS Growth
- +8.3%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 12 bars ยท May 29, 2026 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PreveCeutical Medical Inc. (PRVCF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.01 and up 9.5% across the available one-year price window (May 29, 2026 โ Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +8.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +8.3%, free cash flow -44.3% with operating margin 0.0% and ROIC 100.1%. Stock Foundry combines PRVCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Dec 1, 2025, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +8.3%, while operating margin sits near 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRVCF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PRVCF Max Drawdown
-51.35%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PRVCF and SPY.
Company Overview
PreveCeutical Medical Inc.
Other OTC
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
- Leadership
- Stephen Van Deventer
- IPO Date
- Aug 21, 2017
- Employees
- 7
- Street Address
- 885 Cambie Street
- Mailing
- Vancouver, BC, V6B 0R6
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- 604 416 7777
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- +8.3%
- Free Cash Flow
- -44.3%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 43.2%
- ROIC
- 100.1%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.